CSIMarket



Best Performing Stocks In Medical Equipment & Supplies Industry Over The Past 12 Months



 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 
 

Shares declined by -15.94% on average, in Medical Equipment & Supplies Industry over the past 12 months.

Here are the best performing stocks in Medical Equipment & Supplies Industry.




EUDA

$3.99

$3.3590 532.33%
Last 12 Months


EUDA

$3.99

$3.3590 532.33%



Euda Health Holdings Limited

Euda Health Holdings Limited stock improved 532.33% over the past 12 months.


Euda Health Holdings Limited operates as a digital health platform that facilitates access to healthcare services. They offer a range of online health consultations and concierge services, enabling users to connect with healthcare professionals and receive personalized medical advice and treatment. Their business model focuses on leveraging technology to streamline the healthcare experience and improve access to quality care for individuals seeking medical assistance.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 80.565 mill. $ 11.244 mill. $ -27.358 mill. 20 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 80.565 mill.


$ 11.244 mill.


$ -27.358 mill.

Employees Shares Outstanding P/E

-


20 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MYO

$4.59

$3.7670 457.72%
Last 12 Months


MYO

$4.59

$3.7670 457.72%



Myomo Inc

Myomo Inc stock improved 457.72% over the past 12 months.


Myomo Inc*s business model revolves around the development and commercialization of advanced medical devices, specifically myoelectric orthotics for individuals with neuromuscular disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 161.873 mill. $ 17.258 mill. $ -7.855 mill. 35 mill. - Y/Y 13.12 %
Market Cap. Revenues TTM Net Income TTM

$ 161.873 mill.


$ 17.258 mill.


$ -7.855 mill.

Employees Shares Outstanding P/E

-


35 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 13.12 %


MRQ Y/Y - %



TIVC

$0.343

$0.2766 416.57%
Last 12 Months


TIVC

$0.343

$0.2766 416.57%



Tivic Health Systems Inc

Tivic Health Systems Inc stock improved 416.57% over the past 12 months.


Tivic Health Systems Inc is a company that operates on a direct-to-consumer business model. They develop and sell at-home medical devices for various health conditions, providing customers with the convenience of accessing healthcare solutions from the comfort of their own homes. By cutting out intermediaries and selling directly to consumers, Tivic Health Systems aims to deliver their products more efficiently and establish a direct relationship with their customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.408 mill. $ 1.331 mill. $ -9.139 mill. 1 mill. - Y/Y -40.88 %
Market Cap. Revenues TTM Net Income TTM

$ 0.408 mill.


$ 1.331 mill.


$ -9.139 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -40.88 %


MRQ Y/Y - %



WGS

$32.8

$25.8500 371.94%
Last 12 Months


WGS

$32.8

$25.8500 371.94%



Genedx Holdings Corp

Genedx Holdings Corp shares went up 371.94% over the past 12 months.


Genedx Holdings Corp operates as a genetic testing company, offering molecular and biochemical testing services for various genetic disorders and diseases. The company generates revenue by providing testing services to medical professionals and institutions around the world, aiding in accurate diagnosis and treatment planning for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 854.839 mill. $ 221.278 mill. $ -135.017 mill. 26 mill. - Y/Y 44.67 %
Market Cap. Revenues TTM Net Income TTM

$ 854.839 mill.


$ 221.278 mill.


$ -135.017 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 44.67 %


MRQ Y/Y - %



GCTK

$1.67

$1.2702 317.71%
Last 12 Months


GCTK

$1.67

$1.2702 317.71%



Glucotrack Inc

Glucotrack Inc stock went up 317.71% over the past 12 months.


Glucotrack Inc*s business model is focused on developing and marketing innovative non-invasive glucose monitoring devices for individuals with diabetes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 41.683 mill. $ - mill. $ 8.738 mill. 25 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 41.683 mill.


$ - mill.


$ 8.738 mill.

Employees Shares Outstanding P/E

-


25 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y 127.60 %



INVO

$0.7883

$0.5933 304.26%
Last 12 Months


INVO

$0.7883

$0.5933 304.26%



Invo Bioscience Inc

Invo Bioscience Inc shares went up 304.26% over the past 12 months.


Invo Bioscience Inc operates on a business model focused on developing and commercializing advanced medical devices in the field of reproductive health. Their flagship product, INVOcell, is a novel fertility treatment that allows fertilization and early embryo development to occur within the woman*s body. This innovative approach provides a more affordable and accessible option for couples seeking assisted reproductive technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.997 mill. $ 4.249 mill. $ -7.080 mill. 4 mill. - Y/Y 352.92 %
Market Cap. Revenues TTM Net Income TTM

$ 2.997 mill.


$ 4.249 mill.


$ -7.080 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 352.92 %


MRQ Y/Y - %



RDGL

$0.185

$0.1313 244.51%
Last 12 Months


RDGL

$0.185

$0.1313 244.51%



Vivos Inc

Vivos Inc shares improved 244.51% over the past 12 months.


Vivos Inc operates as a biotechnology company that focuses on developing and commercializing products for regenerative medicine and drug discovery. Their business model revolves around the research, development, and sale of innovative therapies and diagnostics targeting various medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 53.553 mill. $ - mill. $ -2.895 mill. 289 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 53.553 mill.


$ - mill.


$ -2.895 mill.

Employees Shares Outstanding P/E

-


289 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NTRB

$6.55

$4.1500 172.92%
Last 12 Months


NTRB

$6.55

$4.1500 172.92%



Nutriband Inc

Nutriband Inc shares improved 172.92% over the past 12 months.


Nutriband Inc operates through a business model focused on developing and commercializing innovative transdermal topicals and supplement products, utilizing their patented Nutrient Delivery System to enhance the absorption and effectiveness of nutraceutical and pharmaceutical ingredients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 59.997 mill. $ 1.969 mill. $ -5.502 mill. 9 mill. - Y/Y -22.56 %
Market Cap. Revenues TTM Net Income TTM

$ 59.997 mill.


$ 1.969 mill.


$ -5.502 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -22.56 %


MRQ Y/Y - %



BWAY

$6.56

$4.1400 171.07%
Last 12 Months


BWAY

$6.56

$4.1400 171.07%



Brainsway Ltd

Brainsway Ltd stock increased 171.07% over the past 12 months.


Brainsway Ltd is a medical device company that focuses on developing and commercializing advanced non-invasive treatments for brain disorders. Their business model revolves around the manufacturing and sale of deep transcranial magnetic stimulation (dTMS) systems, which are used in the treatment of major depressive disorder and obsessive-compulsive disorder, among other conditions. Through partnerships with healthcare providers and licensing agreements, Brainsway aims to expand the accessibility and adoption of their innovative technologies worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ 31.785 mill. $ 4.197 mill. - mill. - Y/Y 16.96 %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ 31.785 mill.


$ 4.197 mill.

Employees Shares Outstanding P/E

-


- mill.


-

Revenue Growth Income Growth

MRQ Y/Y 16.96 %


MRQ Y/Y -68.56 %



PLSE

$18.58

$11.3900 158.41%
Last 12 Months


PLSE

$18.58

$11.3900 158.41%



Pulse Biosciences Inc

Pulse Biosciences Inc shares went up 158.41% over the past 12 months.


Pulse Biosciences Inc*s business model focuses on the development and commercialization of proprietary technology platforms, specifically in the field of nano-pulse stimulation (NPS) technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,025.096 mill. $ - mill. $ -42.546 mill. 55 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1,025.096 mill.


$ - mill.


$ -42.546 mill.

Employees Shares Outstanding P/E

-


55 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



FEMY

$1.14

$0.6980 157.92%
Last 12 Months


FEMY

$1.14

$0.6980 157.92%



Femasys Inc

Femasys Inc stock went up 157.92% over the past 12 months.


Femasys Inc is a medical technology company that focuses on developing and commercializing innovative solutions for women*s healthcare, specifically in the areas of reproductive and urinary health. Their business model involves designing and manufacturing medical devices, obtaining regulatory approvals, and partnering with healthcare providers and distributors to bring their products to market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 24.824 mill. $ 1.049 mill. $ -14.900 mill. 22 mill. - Y/Y -7.77 %
Market Cap. Revenues TTM Net Income TTM

$ 24.824 mill.


$ 1.049 mill.


$ -14.900 mill.

Employees Shares Outstanding P/E

-


22 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -7.77 %


MRQ Y/Y - %



TNON

$0.7714

$0.4464 137.35%
Last 12 Months


TNON

$0.7714

$0.4464 137.35%



Tenon Medical Inc

Tenon Medical Inc stock went up 137.35% over the past 12 months.


Tenon Medical Inc is a healthcare company that operates on a subscription-based business model, providing medical services and products to subscribers. The company offers a range of medical solutions, including telemedicine consultations, prescription medications, and home delivery of healthcare supplies. Tenon Medical Inc generates revenue through monthly or annual subscription fees, complemented by additional revenue streams from sales of medical products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,755.706 mill. $ 2.397 mill. $ -20.352 mill. 2,276 mill. - Y/Y 353.85 %
Market Cap. Revenues TTM Net Income TTM

$ 1,755.706 mill.


$ 2.397 mill.


$ -20.352 mill.

Employees Shares Outstanding P/E

-


2,276 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 353.85 %


MRQ Y/Y - %



PNTG

$25.62

$14.1000 122.40%
Last 12 Months


PNTG

$25.62

$14.1000 122.40%



The Pennant Group Inc

The Pennant Group Inc shares improved 122.40% over the past 12 months.


The Pennant Group Inc*s business model involves providing healthcare services through a network of subsidiaries, including home health, hospice, and senior living facilities.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 778.925 mill. $ 575.342 mill. $ 16.971 mill. 30 mill. 47.12 Y/Y 24.08 %
Market Cap. Revenues TTM Net Income TTM

$ 778.925 mill.


$ 575.342 mill.


$ 16.971 mill.

Employees Shares Outstanding P/E

4,800


30 mill.


47.12

Revenue Growth Income Growth

MRQ Y/Y 24.08 %


MRQ Y/Y 153.28 %



PAVM

$0.859

$0.4515 110.80%
Last 12 Months


PAVM

$0.859

$0.4515 110.80%



Pavmed Inc

Pavmed Inc stock increased 110.80% over the past 12 months.


Pavmed Inc is a medical device company that focuses on developing and commercializing innovative products for various medical fields. The company*s business model revolves around identifying unmet medical needs, acquiring proprietary rights to potential products, and advancing them through development stages to obtain regulatory approvals and market them.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.469 mill. $ 3.472 mill. $ -75.561 mill. 9 mill. - Y/Y 90.83 %
Market Cap. Revenues TTM Net Income TTM

$ 7.469 mill.


$ 3.472 mill.


$ -75.561 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 90.83 %


MRQ Y/Y - %



CATX

$12.91

$6.5500 102.99%
Last 12 Months


CATX

$12.91

$6.5500 102.99%



Perspective Therapeutics Inc

Perspective Therapeutics Inc stock went up 102.99% over the past 12 months.


Perspective Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative therapeutic solutions. Their business model involves conducting extensive research and development to create novel drug candidates targeting specific diseases. They aim to collaborate with pharmaceutical companies and seek partnerships to further develop and commercialize their products, ultimately making a positive impact on patients* lives.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,531.872 mill. $ - mill. $ 2.651 mill. 274 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 3,531.872 mill.


$ - mill.


$ 2.651 mill.

Employees Shares Outstanding P/E

-


274 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



PRCT

$69.35

$31.8700 85.03%
Last 12 Months


PRCT

$69.35

$31.8700 85.03%



Procept Biorobotics Corporation

Procept Biorobotics Corporation stock improved 85.03% over the past 12 months.


Procept Biorobotics Corporation follows a business model focused on developing medical robotics solutions for urology procedures. Their flagship product, the AquaBeam System, utilizes waterjet technology to perform minimally invasive surgeries for patients with benign prostatic hyperplasia. The company aims to improve patient outcomes and reduce healthcare costs by providing an innovative and efficient alternative to traditional surgical methods.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,537.613 mill. $ 155.679 mill. $ -103.370 mill. 51 mill. - Y/Y 80.44 %
Market Cap. Revenues TTM Net Income TTM

$ 3,537.613 mill.


$ 155.679 mill.


$ -103.370 mill.

Employees Shares Outstanding P/E

-


51 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 80.44 %


MRQ Y/Y - %



NVNO

$5.99

$2.7200 83.18%
Last 12 Months


NVNO

$5.99

$2.7200 83.18%



Envveno Medical Corporation

Envveno Medical Corporation stock went up 83.18% over the past 12 months.


Envveno Medical Corporation is a medical technology company that focuses on developing and manufacturing innovative healthcare products. Their business model involves conducting extensive research and development to create cutting-edge medical solutions, collaborating with healthcare professionals and institutions to ensure effective implementation, and commercializing their products through strategic partnerships and distribution networks worldwide. By providing advanced medical technologies, Envveno Medical aims to improve patient outcomes and enhance the overall healthcare experience.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 96.181 mill. $ - mill. $ -22.411 mill. 16 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 96.181 mill.


$ - mill.


$ -22.411 mill.

Employees Shares Outstanding P/E

-


16 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NXL

$1.42

$0.6203 77.57%
Last 12 Months


NXL

$1.42

$0.6203 77.57%



Nexalin Technology Inc

Nexalin Technology Inc shares increased 77.57% over the past 12 months.


Nexalin Technology Inc is a company that operates on a business model centered around providing innovative neuromodulation therapies. Their approach involves utilizing proprietary technology to offer non-invasive treatment options for mental health disorders such as depression, anxiety, and addiction. By delivering safe and effective solutions, Nexalin aims to improve the quality of life for their patients, revolutionizing the field of neuromodulation.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10.560 mill. $ -1,754.532 mill. $ -4.508 mill. 7 mill. - Y/Y -28.96 %
Market Cap. Revenues TTM Net Income TTM

$ 10.560 mill.


$ -1,754.532 mill.


$ -4.508 mill.

Employees Shares Outstanding P/E

-


7 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -28.96 %


MRQ Y/Y - %



BVS

$6.55

$2.8600 77.51%
Last 12 Months


BVS

$6.55

$2.8600 77.51%



Bioventus Inc

Bioventus Inc shares increased 77.51% over the past 12 months.


Bioventus Inc is a medical technology company that focuses on developing and commercializing orthobiologic solutions for musculoskeletal conditions. They offer a range of products and services, including orthobiologics, braces, and devices, aimed at improving patient outcomes and quality of life.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 415.140 mill. $ 522.654 mill. $ -27.160 mill. 63 mill. - Y/Y 8.80 %
Market Cap. Revenues TTM Net Income TTM

$ 415.140 mill.


$ 522.654 mill.


$ -27.160 mill.

Employees Shares Outstanding P/E

-


63 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 8.80 %


MRQ Y/Y - %



NPCE

$7.44

$3.2400 77.14%
Last 12 Months


NPCE

$7.44

$3.2400 77.14%



Neuropace Inc

Neuropace Inc shares increased 77.14% over the past 12 months.


Neuropace Inc*s business model revolves around the development and commercialization of medical devices for the treatment of neurological disorders, primarily focusing on epilepsy.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 210.442 mill. $ 64.020 mill. $ -35.681 mill. 28 mill. - Y/Y 35.61 %
Market Cap. Revenues TTM Net Income TTM

$ 210.442 mill.


$ 64.020 mill.


$ -35.681 mill.

Employees Shares Outstanding P/E

-


28 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 35.61 %


MRQ Y/Y - %



SRTS

$6.17

$2.6500 75.28%
Last 12 Months


SRTS

$6.17

$2.6500 75.28%



Sensus Healthcare Inc

Sensus Healthcare Inc shares improved 75.28% over the past 12 months.


Sensus Healthcare Inc operates through a business model centered around the development, manufacturing, and marketing of advanced medical devices, primarily focused on providing non-invasive treatments for various skin conditions and cancers. The company aims to deliver effective and efficient solutions to healthcare providers, enabling them to deliver exceptional patient care and improve outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 100.388 mill. $ 24.943 mill. $ -0.896 mill. 16 mill. - Y/Y -56.74 %
Market Cap. Revenues TTM Net Income TTM

$ 100.388 mill.


$ 24.943 mill.


$ -0.896 mill.

Employees Shares Outstanding P/E

-


16 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -56.74 %


MRQ Y/Y - %



AORT

$27.28

$11.5700 73.65%
Last 12 Months


AORT

$27.28

$11.5700 73.65%



Artivion Inc

Artivion Inc shares improved 73.65% over the past 12 months.


Artivion Inc*s business model focuses on providing innovative solutions in the field of art and technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,306.330 mill. $ 366.893 mill. $ -9.625 mill. 48 mill. - Y/Y 16.48 %
Market Cap. Revenues TTM Net Income TTM

$ 1,306.330 mill.


$ 366.893 mill.


$ -9.625 mill.

Employees Shares Outstanding P/E

1


48 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 16.48 %


MRQ Y/Y - %



ZIMV

$18.68

$7.8300 72.17%
Last 12 Months


ZIMV

$18.68

$7.8300 72.17%



Zimvie Inc

Zimvie Inc shares went up 72.17% over the past 12 months.


Zimvie Inc is a technology company that operates in the entertainment industry, offering a platform for users to stream and watch movies and TV shows online. They generate revenue by charging a subscription fee to users who access their extensive library of content.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ 887.759 mill. $ -67.142 mill. - mill. - Y/Y -13.89 %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ 887.759 mill.


$ -67.142 mill.

Employees Shares Outstanding P/E

-


- mill.


-

Revenue Growth Income Growth

MRQ Y/Y -13.89 %


MRQ Y/Y - %



GKOS

$121.09

$49.4500 69.03%
Last 12 Months


GKOS

$121.09

$49.4500 69.03%



Glaukos Corp

Glaukos Corp shares improved 69.03% over the past 12 months.


Glaukos Corp is a medical technology company that specializes in developing and commercializing ophthalmic treatment solutions. Their business model revolves around providing innovative products for the surgical treatment of glaucoma and other eye disorders. Through research, development, and partnerships, Glaukos aims to improve patient outcomes by offering minimally invasive, cost-effective treatments.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6,003.642 mill. $ 325.601 mill. $ -140.873 mill. 50 mill. - Y/Y 15.51 %
Market Cap. Revenues TTM Net Income TTM

$ 6,003.642 mill.


$ 325.601 mill.


$ -140.873 mill.

Employees Shares Outstanding P/E

900


50 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 15.51 %


MRQ Y/Y - %



INO

$11.31

$4.5672 67.73%
Last 12 Months


INO

$11.31

$4.5672 67.73%



Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc shares went up 67.73% over the past 12 months.


Inovio Pharmaceuticals Inc is a biotechnology company that focuses on the development and commercialization of immunotherapies for the treatment of various diseases, including cancers and infectious diseases. Their business model involves leveraging their proprietary platforms, such as DNA-based technology and electroporation, to design and develop novel vaccines and therapies which are then advanced through clinical trials and potential partnerships for further commercialization.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 263.427 mill. $ 8.143 mill. $ -124.938 mill. 23 mill. - Y/Y -35.39 %
Market Cap. Revenues TTM Net Income TTM

$ 263.427 mill.


$ 8.143 mill.


$ -124.938 mill.

Employees Shares Outstanding P/E

-


23 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -35.39 %


MRQ Y/Y - %



CDRE

$36.81

$14.7700 67.01%
Last 12 Months


CDRE

$36.81

$14.7700 67.01%



Cadre Holdings inc

Cadre Holdings Inc stock increased 67.01% over the past 12 months.


Cadre Holdings Inc*s business model revolves around using technology to streamline and facilitate real estate investment opportunities, connecting investors with opportunities they may not typically have access to while providing data-driven insights for informed decision-making.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,419.180 mill. $ 507.606 mill. $ 38.567 mill. 39 mill. 36.46 Y/Y 23.16 %
Market Cap. Revenues TTM Net Income TTM

$ 1,419.180 mill.


$ 507.606 mill.


$ 38.567 mill.

Employees Shares Outstanding P/E

-


39 mill.


36.46

Revenue Growth Income Growth

MRQ Y/Y 23.16 %


MRQ Y/Y -1.06 %



UFPT

$305.55

$122.0700 66.53%
Last 12 Months


UFPT

$305.55

$122.0700 66.53%



Ufp Technologies Inc

Ufp Technologies Inc stock went up 66.53% over the past 12 months.


UFP Technologies Inc*s business model involves the manufacturing and customization of innovative, foam-based solutions for various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,364.040 mill. $ 405.555 mill. $ 47.878 mill. 8 mill. 49.29 Y/Y 6.48 %
Market Cap. Revenues TTM Net Income TTM

$ 2,364.040 mill.


$ 405.555 mill.


$ 47.878 mill.

Employees Shares Outstanding P/E

722


8 mill.


49.29

Revenue Growth Income Growth

MRQ Y/Y 6.48 %


MRQ Y/Y 30.33 %



MODD

$1.59

$0.6234 64.49%
Last 12 Months


MODD

$1.59

$0.6234 64.49%



Modular Medical Inc

Modular Medical Inc stock increased 64.49% over the past 12 months.


Modular Medical Inc operates with a business model focused on designing and manufacturing modular medical units, offering cost-effective and customizable solutions for healthcare providers looking to expand their facilities rapidly and efficiently. They aim to deliver innovative and turnkey solutions that can be easily deployed and scaled to meet the specific needs of their clients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 35.839 mill. $ - mill. $ -16.760 mill. 23 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 35.839 mill.


$ - mill.


$ -16.760 mill.

Employees Shares Outstanding P/E

-


23 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NEPH

$2.29

$0.8810 62.53%
Last 12 Months


NEPH

$2.29

$0.8810 62.53%



Nephros Inc

Nephros Inc shares went up 62.53% over the past 12 months.


Nephros Inc operates under a business model focused on developing and marketing specialty medical products and technologies for renal disease patients. The company aims to provide innovative filtration and purification solutions to improve the quality of life for individuals with renal disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 24.045 mill. $ 13.405 mill. $ -1.575 mill. 11 mill. - Y/Y 67.97 %
Market Cap. Revenues TTM Net Income TTM

$ 24.045 mill.


$ 13.405 mill.


$ -1.575 mill.

Employees Shares Outstanding P/E

-


11 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 67.97 %


MRQ Y/Y - %



CSL

$430.54

$162.1400 60.41%
Last 12 Months


CSL

$430.54

$162.1400 60.41%



Carlisle Companies Incorporated

Carlisle Companies Incorporated shares increased 60.41% over the past 12 months.


Carlisle Companies Incorporated operates as a diversified manufacturing company that supplies a range of products to various industries globally. Its business model is focused on acquiring and integrating companies that manufacture niche products and possess expertise in their respective markets. By leveraging these acquisitions, Carlisle aims to generate consistent revenue growth and enhance its profitability through operational efficiencies and market expansion opportunities.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 20,838.136 mill. $ 5,061.000 mill. $ 754.200 mill. 48 mill. 28.68 Y/Y -24.62 %
Market Cap. Revenues TTM Net Income TTM

$ 20,838.136 mill.


$ 5,061.000 mill.


$ 754.200 mill.

Employees Shares Outstanding P/E

12,000


48 mill.


28.68

Revenue Growth Income Growth

MRQ Y/Y -24.62 %


MRQ Y/Y 10.39 %



TMDX

$142.19

$52.0300 57.71%
Last 12 Months


TMDX

$142.19

$52.0300 57.71%



Transmedics Group Inc

Transmedics Group Inc stock went up 57.71% over the past 12 months.


Transmedics Group Inc operates on a business model focused on medical technology. They develop and commercialize portable systems to facilitate the transplantation of organs and tissues. Their innovative platforms provide organ preservation, transportation, and monitoring solutions, aiming to improve patient outcomes in organ transplantation procedures.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4,637.393 mill. $ 191.824 mill. $ -35.779 mill. 33 mill. - Y/Y 158.65 %
Market Cap. Revenues TTM Net Income TTM

$ 4,637.393 mill.


$ 191.824 mill.


$ -35.779 mill.

Employees Shares Outstanding P/E

194


33 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 158.65 %


MRQ Y/Y - %



DCTH

$8.07

$2.9400 57.31%
Last 12 Months


DCTH

$8.07

$2.9400 57.31%



Delcath Systems Inc

Delcath Systems Inc stock went up 57.31% over the past 12 months.


Delcath Systems Inc is a medical technology company focused on the development and commercialization of innovative products to treat cancers. Their business model revolves around the manufacture and sale of the proprietary Delcath Hepatic Delivery System, a targeted chemotherapy system designed to deliver high-dose treatment directly to the liver. The company also generates revenue through the sale of consumables and accessories used in conjunction with their system.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 200.840 mill. $ 4.607 mill. $ -49.789 mill. 25 mill. - Y/Y 425.80 %
Market Cap. Revenues TTM Net Income TTM

$ 200.840 mill.


$ 4.607 mill.


$ -49.789 mill.

Employees Shares Outstanding P/E

-


25 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 425.80 %


MRQ Y/Y - %



TALK

$2.14

$0.7700 56.20%
Last 12 Months


TALK

$2.14

$0.7700 56.20%



Talkspace Inc

Talkspace Inc stock went up 56.20% over the past 12 months.


Talkspace Inc is an online therapy platform that connects users with licensed therapists through a messaging app.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 356.461 mill. $ 137.071 mill. $ -122.947 mill. 167 mill. - Y/Y 29.04 %
Market Cap. Revenues TTM Net Income TTM

$ 356.461 mill.


$ 137.071 mill.


$ -122.947 mill.

Employees Shares Outstanding P/E

500


167 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 29.04 %


MRQ Y/Y - %



TNDM

$46.07

$16.4800 55.69%
Last 12 Months


TNDM

$46.07

$16.4800 55.69%



Tandem Diabetes Care Inc

Tandem Diabetes Care Inc stock went up 55.69% over the past 12 months.


Tandem Diabetes Care Inc is a medical device company that specializes in designing, manufacturing, and marketing insulin pumps. Their business model revolves around developing and selling technologically advanced insulin delivery systems to improve the quality of life for individuals with diabetes. By constantly innovating and focusing on customer needs, Tandem Diabetes Care Inc aims to capture a significant portion of the insulin pump market and establish itself as a trusted leader in the industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,009.569 mill. $ 734.815 mill. $ -216.356 mill. 65 mill. - Y/Y -13.07 %
Market Cap. Revenues TTM Net Income TTM

$ 3,009.569 mill.


$ 734.815 mill.


$ -216.356 mill.

Employees Shares Outstanding P/E

1,630


65 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -13.07 %


MRQ Y/Y - %



RXST

$47.72

$16.7600 54.13%
Last 12 Months


RXST

$47.72

$16.7600 54.13%



Rxsight Inc

Rxsight Inc shares went up 54.13% over the past 12 months.


Rxsight Inc*s business model revolves around providing innovative solutions in personalized vision correction through the use of adjustable intraocular lenses (IOLs).


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,701.810 mill. $ 75.323 mill. $ -55.041 mill. 36 mill. - Y/Y 72.26 %
Market Cap. Revenues TTM Net Income TTM

$ 1,701.810 mill.


$ 75.323 mill.


$ -55.041 mill.

Employees Shares Outstanding P/E

-


36 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 72.26 %


MRQ Y/Y - %



APT

$5.8

$1.9800 51.83%
Last 12 Months


APT

$5.8

$1.9800 51.83%



Alpha Pro Tech Ltd

Alpha Pro Tech Ltd shares went up 51.83% over the past 12 months.


Alpha Pro Tech Ltd is a company that develops, manufactures, and distributes a range of disposable protective apparel, building supply products, and infection control products for the healthcare industry. They generate revenue by selling these products to various customers, including hospitals, distributors, and other industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 66.058 mill. $ 60.446 mill. $ 9.667 mill. 11 mill. 16.01 Y/Y -2.78 %
Market Cap. Revenues TTM Net Income TTM

$ 66.058 mill.


$ 60.446 mill.


$ 9.667 mill.

Employees Shares Outstanding P/E

-


11 mill.


16.01

Revenue Growth Income Growth

MRQ Y/Y -2.78 %


MRQ Y/Y 4.26 %



LAKE

$22.94

$7.7700 51.22%
Last 12 Months


LAKE

$22.94

$7.7700 51.22%



Lakeland Industries Inc

Lakeland Industries Inc stock went up 51.22% over the past 12 months.


Lakeland Industries Inc*s business model is to design, manufacture, and distribute a wide range of safety garments and protective clothing for various industries and hazards.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 173.941 mill. $ 120.455 mill. $ 2.206 mill. 8 mill. 26.08 Y/Y 26.51 %
Market Cap. Revenues TTM Net Income TTM

$ 173.941 mill.


$ 120.455 mill.


$ 2.206 mill.

Employees Shares Outstanding P/E

1,000


8 mill.


26.08

Revenue Growth Income Growth

MRQ Y/Y 26.51 %


MRQ Y/Y 25.23 %



BSX

$77.69

$24.9000 47.17%
Last 12 Months


BSX

$77.69

$24.9000 47.17%



Boston Scientific Corporation

Boston Scientific Corporation stock improved 47.17% over the past 12 months.


Boston Scientific Corporation*s business model revolves around designing, developing, and manufacturing a wide range of medical devices that are used in various medical specialties. The company focuses on creating innovative products that address unmet medical needs and improve patient outcomes. They sell these devices to healthcare professionals and hospitals worldwide, leveraging their strong sales and distribution networks. Additionally, Boston Scientific actively invests in research and development to continuously bring new technologies and solutions to the market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 115,113.273 mill. $ 14,709.000 mill. $ 1,771.000 mill. 1,482 mill. 67.38 Y/Y 13.81 %
Market Cap. Revenues TTM Net Income TTM

$ 115,113.273 mill.


$ 14,709.000 mill.


$ 1,771.000 mill.

Employees Shares Outstanding P/E

41,000


1,482 mill.


67.38

Revenue Growth Income Growth

MRQ Y/Y 13.81 %


MRQ Y/Y 57.01 %



ITGR

$120.23

$36.8900 44.26%
Last 12 Months


ITGR

$120.23

$36.8900 44.26%



Integer Holdings Corporation

Integer Holdings Corporation shares improved 44.26% over the past 12 months.


Integer Holdings Corporation is a leading medical device outsource manufacturer that provides innovative and cost-effective solutions to the healthcare industry. Their business model revolves around collaborating with medical technology companies to design, develop, and manufacture products that improve patient outcomes. With a focus on quality, compliance, and efficiency, Integer aims to deliver customized solutions and seamless customer experiences.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4,207.208 mill. $ 1,631.344 mill. $ 98.093 mill. 35 mill. 41.81 Y/Y 9.25 %
Market Cap. Revenues TTM Net Income TTM

$ 4,207.208 mill.


$ 1,631.344 mill.


$ 98.093 mill.

Employees Shares Outstanding P/E

8,500


35 mill.


41.81

Revenue Growth Income Growth

MRQ Y/Y 9.25 %


MRQ Y/Y 56.97 %



SRDX

$42.17

$12.1400 40.43%
Last 12 Months


SRDX

$42.17

$12.1400 40.43%



Surmodics Inc

Surmodics Inc stock went up 40.43% over the past 12 months.


Surmodics Inc operates on a business model centered around the development and commercialization of innovative medical device and pharmaceutical technologies. The company focuses on creating surface modification technologies, such as drug delivery coatings, that enhance the performance and functionality of medical devices and improve therapeutic outcomes. Surmodics Inc collaborates with industry partners to license or directly manufacture and sell their proprietary products in various medical fields.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 588.847 mill. $ 133.718 mill. $ -10.613 mill. 14 mill. - Y/Y 123.70 %
Market Cap. Revenues TTM Net Income TTM

$ 588.847 mill.


$ 133.718 mill.


$ -10.613 mill.

Employees Shares Outstanding P/E

316


14 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 123.70 %


MRQ Y/Y - %




 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com